(reminder -- primary device used to inject Hizentra is REPR's Freedom60 which patients use for life and each buy $300 worth of tubing sets a year from REPR at huge profit margins)
Some tidbits:
(1) About 10 million have the disorder that Hizentra treats.
(2) Hizentra greatly improves the quality of life vs. anything else out there. Hizentra was FDA approved just this past March.
(3) Sales of these types of drugs jumped 35% for the year ending in June and are expected to grow 20% for the next 3-5 years.
(4) Patients are switching in huge numbers from other drugs to the at-home delivery method (which pretty much requires a purchase of REPR's Freedom60 and $300 a year of tubing sets0
(5) A study published this past July shows the at-home users (Freedom60) of the same drug saw "their antibody levels by an average of 5.4 percent after a year and used 28 percent less medicine"
Market Data 
Markets 
AI
